Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients
Uğur Gezer, Abel J. Bronkhorst, Stefan Holdenrieder
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3042-3042
Open Access | Times Cited: 24

Showing 24 citing articles:

Omics-Based Investigations of Breast Cancer
Anca-Narcisa Neagu, Danielle Whitham, Pathea Bruno, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4768-4768
Open Access | Times Cited: 27
Liquid biopsy: Cell-free DNA based analysis in breast cancer
Konstantinos Venetis, Giulia Cursano, Carlo Pescia, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100002-100002
Open Access | Times Cited: 19
Biomarker-specific biosensors revolutionise breast cancer diagnosis
Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Sandhiya Viswanathan, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117792-117792
Closed Access | Times Cited: 8
Fe Single-Atom Carbon Dots Nanozyme Collaborated with Nucleic Acid Exonuclease III-Driven DNA Walker Cascade Amplification Strategy for Circulating Tumor DNA Detection
Yanyi Long, Jiaying Zhao, Wanting Ma, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 12, pp. 4774-4782
Closed Access | Times Cited: 7
Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications
P Salu, Katie M. Reindl
Cancers (2024) Vol. 16, Iss. 6, pp. 1213-1213
Open Access | Times Cited: 7
Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, et al.
Molecular Oncology (2025)
Open Access
Medical diagnostic value of digital PCR (dPCR): A systematic review
Sophia Nazir
Biomedical Engineering Advances (2023) Vol. 6, pp. 100092-100092
Open Access | Times Cited: 17
Exploring the Multifaceted Biologically Relevant Roles of circRNAs: From Regulation, Translation to Biomarkers
Parsa Hoque, Brigette Romero, Robert E. Akins, et al.
Cells (2023) Vol. 12, Iss. 24, pp. 2813-2813
Open Access | Times Cited: 9
Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer
Md. Sajedul Islam, Vinod Gopalan, Alfred K. Lam, et al.
Biosensors and Bioelectronics (2023) Vol. 239, pp. 115611-115611
Open Access | Times Cited: 8
Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer
Gabrielle P. Dailey, Christopher A. Rabiola, Gangjun Lei, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha O. Hasenleithner, Rupert Bartsch, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 2
The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization
Abel J. Bronkhorst, Stefan Holdenrieder
Medizinische Genetik (2023) Vol. 35, Iss. 4, pp. 201-235
Open Access | Times Cited: 6
Routine molecular applications and recent advances in breast cancer diagnostics
Gabriella Pankotai-Bodó, Orsolya Oláh‐Németh, Farkas Sükösd, et al.
Journal of Biotechnology (2023) Vol. 380, pp. 20-28
Open Access | Times Cited: 6
ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
Margaux Betz, Vincent Massard, Pauline Gilson, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5169-5169
Open Access | Times Cited: 5
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
Alberto Ranghiero, Chiara Frascarelli, Giulia Cursano, et al.
Cytopathology (2023) Vol. 34, Iss. 6, pp. 519-529
Open Access | Times Cited: 5
Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients
Victoria Sánchez-Martín, Esperanza López-López, Diego Reguero-Paredes, et al.
Clinica Chimica Acta (2023) Vol. 552, pp. 117673-117673
Open Access | Times Cited: 5
Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis
Niall J. O’Sullivan, Hugo C. Temperley, Eimear T. Kyle, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Cell-Free Nucleic Acids: Physico-Chemical Properties, Analytical Considerations, and Clinical Applications
Abel J. Bronkhorst, Stefan Holdenrieder
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2312-2312
Open Access | Times Cited: 3
Designing and Validation of a Droplet Digital PCR Procedure for Diagnosis and Accurate Quantification of Nervous Necrosis Virus in the Mediterranean Area
Sandra Souto, José G. Olveira, Carmen López‐Vázquez, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1155-1155
Open Access | Times Cited: 3
Designing and Validation of a Droplet Digital PCR Procedure for Diagnosis and Accurate Quantification of Nervous Necrosis Virus
Sandra Souto, José G. Olveira, Carmen López‐Vázquez, et al.
(2023)
Open Access | Times Cited: 2
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
Juan Carlos Laguna, B. Pastor, I. Nalda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1420-1431
Closed Access
Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR
Stavroula Smilkou, Aliki Ntzifa, Dimitra Stergiopoulou, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100154-100154
Open Access
Molecular methods in cancer diagnostics: a short review
Tanushree Budhbaware, Jaishriram Rathored, Sandesh Shende
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Development of two step reverse transcription droplet digital PCR (RT-ddPCR) for simultaneous identification of saliva and semen
S. Lee, Un Na Koh, Rita Fakhr, et al.
Legal Medicine (2024) Vol. 71, pp. 102536-102536
Closed Access
Page 1

Scroll to top